Ing. Jan Verner, Ph.D.
Research specialist, Vladimír Rotrekl Research Group
correspondence Address:
Kamenice 753/5, 625 00 Brno
office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno
phone: | +420 549 49 5437 |
---|---|
e‑mail: | jan.verner@ceitec.muni.cz |
social and academic networks: |
---|
Total number of publications: 60
2024
-
STROMAL CELLS ENGINEERED TO EXPRESS T CELL FACTORS INDUCE ROBUST CLL CELL PROLIFERATION IN VITRO AND IN PDX COTRANSPLANTATIONS ALLOWING THE IDENTIFICATION OF ANTI-PROLIFERATIVE DRUGS
Year: 2024, type: Conference abstract
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI
2023
-
Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation.
Year: 2023, type: Conference abstract
-
The role of casein kinase 1 inhibition in treatment of chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
2022
-
GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
Year: 2022, type: Conference abstract
-
Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models.
Year: 2022, type: Conference abstract
-
PYCARD acts as tumor suppressor in osteosarcoma
Year: 2022, type: Conference abstract
-
Transcription factor c-Myb: novel prognostic factor in osteosarcoma
Clinical & Experimental Metastasis, year: 2022, volume: 39, edition: 2, DOI
-
Versatile coculture systém to study chronic lymhocytic leukemia proliferation.
Year: 2022, type: Conference abstract
2021
-
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
Blood, year: 2021, volume: 138, edition: 9, DOI